Physician profile
Samantha J Crusenberry
NPI 1538767041
$1,265.68
in general payments reported to CMS, 2019-2025
13 companies · $33.18 in 2025
The $33.18 reported for 2025 was less than what a typical Women'S Health Care, Ambulatory provider received nationally (typical 2025 total: $102).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $286 · 2022: $346 · 2023: $362 · 2024: $238 · 2025: $33.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $344.32 | 2021-2025 | |
| Exeltis, USA INC. | $242.40 | 2021-2024 | Slynd |
| Therapeuticsmd, INC. | $133.50 | 2021 | |
| Pfizer INC. | $130.64 | 2022-2024 | |
| Myovant Sciences INC. | $104.90 | 2021-2022 | |
| Coopersurgical, INC. | $85.34 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $55.46 | 2022-2024 | Nexplanon |
| Astellas Pharma US INC | $53.09 | 2023-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $39.95 | 2023-2024 | Novasure, Coolseal Generator, Acessa Provu System |
| Sumitomo Pharma America, INC. | $21.91 | 2024 | Myfembree |
| Medline Industries Lp | $19.27 | 2022 | |
| Evofem Biosciences, INC. | $18.41 | 2022 | |
| Smith+Nephew, INC. | $16.49 | 2023 | Pico, Renasys Touch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Crusenberry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.